Figure 7D demonstrated that the overexpression of SLC2A3 was associated with an impaired cancer-immunity cycle. Further investigation uncovered that M2 macrophage polarization factors were also upregulated (Figure 7E). The gene discussed is SLC2A3; the disease is cancer.